Aperio Group LLC raised its position in shares of Mead Johnson Nutrition Co. (NYSE:MJN) by 11.5% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 63,167 shares of the company’s stock after buying an additional 6,498 shares during the period. Aperio Group LLC’s holdings in Mead Johnson Nutrition were worth $4,991,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. FMR LLC boosted its position in Mead Johnson Nutrition by 11.8% in the second quarter. FMR LLC now owns 13,045,067 shares of the company’s stock worth $1,183,840,000 after buying an additional 1,378,877 shares in the last quarter. Vanguard Group Inc. boosted its position in Mead Johnson Nutrition by 1.4% in the second quarter. Vanguard Group Inc. now owns 11,547,883 shares of the company’s stock worth $1,047,971,000 after buying an additional 154,730 shares in the last quarter. American Century Companies Inc. boosted its position in Mead Johnson Nutrition by 15.2% in the second quarter. American Century Companies Inc. now owns 5,544,545 shares of the company’s stock worth $503,167,000 after buying an additional 732,011 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in Mead Johnson Nutrition by 1.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,027,781 shares of the company’s stock worth $456,271,000 after buying an additional 56,360 shares in the last quarter. Finally, Waddell & Reed Financial Inc. boosted its position in Mead Johnson Nutrition by 47.0% in the second quarter. Waddell & Reed Financial Inc. now owns 4,274,094 shares of the company’s stock worth $387,874,000 after buying an additional 1,367,163 shares in the last quarter. Hedge funds and other institutional investors own 94.72% of the company’s stock.

Institutional Ownership by Quarter for Mead Johnson Nutrition (NYSE:MJN)

Mead Johnson Nutrition Co. (NYSE:MJN) traded up 1.09% during trading on Tuesday, hitting $72.51. 1,361,735 shares of the company traded hands. The firm has a 50 day moving average of $75.58 and a 200 day moving average of $82.43. The firm has a market cap of $13.39 billion, a P/E ratio of 26.95 and a beta of 1.43. Mead Johnson Nutrition Co. has a one year low of $65.53 and a one year high of $94.40.

Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings data on Thursday, October 27th. The company reported $0.87 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.01. The firm had revenue of $937.50 million for the quarter, compared to analyst estimates of $933.43 million. Mead Johnson Nutrition had a net margin of 13.26% and a negative return on equity of 119.05%. The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.77 EPS. On average, analysts expect that Mead Johnson Nutrition Co. will post $3.45 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Aperio Group LLC Boosts Position in Mead Johnson Nutrition Co. (MJN)” was published by Financial Market News and is the propert of of Financial Market News. If you are accessing this report on another site, it was stolen and reposted in violation of United States and international copyright law. The original version of this report can be read at http://www.financial-market-news.com/aperio-group-llc-boosts-position-in-mead-johnson-nutrition-co-mjn/1208993/.

A number of research analysts recently commented on MJN shares. Susquehanna reiterated a “hold” rating and issued a $90.00 price objective on shares of Mead Johnson Nutrition in a report on Wednesday, October 19th. JPMorgan Chase & Co. restated an “overweight” rating and set a $105.00 price target on shares of Mead Johnson Nutrition in a research note on Friday, August 5th. Zacks Investment Research cut Mead Johnson Nutrition from a “hold” rating to a “sell” rating in a research note on Tuesday, October 4th. Citigroup Inc. decreased their price target on Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating on the stock in a research note on Thursday, September 8th. Finally, BMO Capital Markets restated an “outperform” rating and set a $96.00 price target (down from $97.00) on shares of Mead Johnson Nutrition in a research note on Saturday, October 8th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $88.33.

In other news, Director Anna C. Catalano sold 656 shares of the stock in a transaction on Monday, October 31st. The shares were sold at an average price of $74.99, for a total transaction of $49,193.44. Following the transaction, the director now owns 8,796 shares in the company, valued at approximately $659,612.04. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.50% of the stock is currently owned by company insiders.

About Mead Johnson Nutrition

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).

Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.